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Background: Pressure ulcers are one of the most common health complaints, which often take months or years
to heal, and affect patients’ morbidity and quality of life. Medical options for pressure ulcers are limited.
Electroacupuncture (EA) has been employed to relieve the symptoms for patients with pressure ulcers, but there
is limited clinical evidence for its effectiveness.
Methods/Design: This study consists of a randomized controlled trial (RCT) with two parallel arms: a control group
and an EA group. Both groups will receive standard wound care (including changing position, using mattresses and
cushions, and a good diet) of five sessions per week for a total of 40 sessions during the 8-week treatment period.
In addition, the EA group will receive the EA intervention. The following outcome measurements will be used in
examination of participants: wound surface area (WSA), visual analogue scale (VAS), and the proportion of ulcers
healed within trial period (PUHTP). All the outcomes will be evaluated at the start of the study, at the end of the
fourth week, at 8 weeks after randomization, and 1 month after treatment cessation.
Discussion: The aim of this study is to evaluate the effectiveness of EA for the treatment of patients with
pressure ulcers.
Trial registration: Chinese Clinical Trial Register: ChiCTR-TRC-11001693
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Pressure ulcers, also known as bedsores or pressure
sores, are regions of localized damage to the skin and
deeper tissue layers affecting muscle, tendon, and bone
[1-3]. These pressure ulcers are caused by unrelieved
pressure or pressure in combination with shear and
usually over bony prominences, such as the sacrum
(tailbone), back, buttocks, heels, back of the head, and
elbows [4,5]. Open ulcers can become a source of pain,
disability, and infection unless they are adequately
treated.
The prevalence and incidence of pressure ulcers differ
according to the method of data collection and classifi-
cation. For example, this type of ulcer is widespread,* Correspondence: sunzhongren2011@163.com
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reproduction in any medium, provided the orwith prevalence rates varying from 8.8% to 53.2% [6,7]
and incidence rates fluctuating from 7% to 71.6% [8,9].
Prevalence rates vary widely depending on patients’ pre-
disposing risk factors, such as poor nutrition, confinement
to a bed or wheelchair, and so on [5,10,11]. Pressure ulcers
are generally graded I, II, III, and IV, according to the
European Pressure Ulcer Advisory Panel and the National
Pressure Ulcer Advisory Panel (EPUAP/NPUAP) [12].
Intervention strategies for pressure ulcers often repre-
sent a great financial burden on healthcare systems. For
example, the annual cost associated with treatment of
pressure ulcers has been estimated to range from £1.4 to
2.1 billion in the UK; broadly equal to the total cost of
community health services [1,13].
Effective and adequate intervention is an important
issue for patients, practitioners, and policy makers. Herbal
medicine, acupuncture, and moxibustion are three effect-
ive traditional Chinese medicine (TCM) therapies and
have been administered for treatment of pressure ulcers in
China [1]. However, the current level of evidence is poorLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Visit times and data collection

























WSA × × × ×
VAS × × × ×
PUHTP × × × ×
Safety
Adverse events × × × ×
EA, electroacupuncture; PUHTP, proportion of ulcers healed within trial period;
VAS, visual analogue scale; WSA, wound surface area; the symbol ‘x’ is used as
a check mark.
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and variation in the composition of acupuncture. Consid-
ering these methodological flaws, we will conduct a trial
to assess the efficacy of electroacupuncture (EA) for pres-
sure ulcers and the feasibility of a large clinical trial.
Methods/Design
Objective
The primary objective of this study is to evaluate the
efficacy of EA treatment for pressure ulcers.
Design
This study will consist of a randomized, assessor- and
analyst-blinded, controlled trial to compare an EA group
with a control group (Figure 1 and Table 1). The trial
will be conducted at the Second Affiliated Hospital of
Heilongjiang University of Chinese Medicine, Heilongjiang
Province, China.
This trial will include an 8-week treatment period and
a 1-month follow-up period. After randomization,
patients will receive a total of 40 session treatments over
a period of 8 weeks. Outcome measurements will be
assessed at baseline (1 week after participants are diag-
nosed with pressure ulcer), as well as at the end of the
fourth week and 8 weeks after randomization, and 1
month after conclusion of the treatment phase. Patients
will be informed that they may be assigned to an EA
group, or control group.
This trial will be carried out according to the princi-










5 Sessions/Week for 8 Weeks
Outcome Assessment at the start of study, the End of the 4th Week 
and the 8th Week
Follow-up (1 month)
Figure 1 Trial flow chart.This study protocol has been approved by the ethical
review boards of the Second Affiliated Hospital of
Heilongjiang University of Chinese Medicine, with per-
mission number LLP2011012. All participants will be
asked to provide written informed consent before enroll-
ment, and will be given sufficient time to reach a decision
to participate and sign the consent form.
Randomization
A randomization scheme will be performed at the
Good Clinical Practice (GCP) Center of the Second
Affiliated Hospital of Heilongjiang University of Chinese
Medicine. This scheme will be used to assign participants
to the EA group and control group in a 1:1 ratio. The
randomization scheme will be generated by the central
computer system. Two separate databases will be set up:
the ‘participants’ database that includes basic participant
information, such as name, contact details, and so on; and
the ‘randomization’ database that holds data of patients
registered on the trial and their allocation [14]. The practi-
tioners participating in the study will not take part in the
randomization process. Patients who meet the inclusion
criteria and agree to provide written informed consent will
be included in the study. The researcher will then contact
the GCP center where the participant’s information is
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patient’s assignation to one of the two study branches
will be sent to the researcher by cell phone or via
email. This procedure will ensure adequate randomization
concealment, and is not influenced by the researcher
taking part in this study.
Blinding
The researchers are in charge of sending randomization
information and also receiving notices of the patient’s
assignation. It is not practical to blind the researchers to
treatment allocations. In addition, it is not possible to
prevent participants from knowing if they have received
EA treatment or standard wound care. However, it is
feasible to blind outcome assessors and statisticians.
Recruitment
Participants will be recruited via advertisements and
posted notices. Advertisements will be broadcast on
local television channels and also published in local
newspapers. Posted notices will be put up on the notice
board of the local hospital. A data compilation form
including all variables of interest and all potential risks
will be completed by the corresponding research center.
The obtained information will be recorded on an elec-
tronic database for subsequent statistical analysis.
Eligibility
Inclusion criteria
Participants will be included if they fulfill the following
criteria: 1) pressure ulcers of grade II or III, according to
EPUAP/NPUAP [12]; 2) duration of one or more pres-
sure ulcers is greater than 3 months; and 3) aged 18 to
75 years old.
Exclusion criteria
Patients with any of the following conditions will be ex-
cluded: 1) undergoing any other therapies which might
interfere with the ability to heal, such as corticosteroid
therapy, radiation therapy, or chemotherapy for cancer;
2) severe diseases, such as severe liver, cardiac, kidney
diseases, and relevant intensive complications, for rea-
sons of safety as well as evaluation of pain intensity for
patients with sensation loss; and 3) medical conditions
for which EA is contraindicated [15], such as ventricular
arrhythmia, atrial fibrillation, using cardiac pacemaker,
history of deep radiation therapy within the local region,
known deep venous thrombosis or thrombophlebitis,
superficial metal ions or metal implants near the area,
pregnancy, or active osteomyelitis.
Intervention
The intervention was designed according to the record
in the ancient book of Yellow Emperor’s Inner Bible, inChapter Lingshu-Guanzhen [16] and according to the
recent study of acupuncture as a treatment for pressure
ulcers [17]. Standard wound care is a non-EA therapy
option in this trial. The EA protocol was developed in
consensus with acupuncturists and experts, who are
good at acupuncture. In addition, this protocol is con-
sistent with the Standards for Reporting Interventions in
Clinical Trials of Acupuncture (STRICTA) guidelines for
the performance of EA studies [18].
Control group
Standard wound care will be used in the control group.
In this study, standard wound care will include moving
around and changing position, using mattresses and
cushions, and a good diet. Keeping moving by moving
around and changing position as much as possible
should be restricted to less than 2 hours. Using mat-
tresses and cushions can reduce the pressure on bony
parts of the body. For patients with pressure ulcers of
grade II, they should use a high specification foam mat-
tress. As for pressure ulcers of grade III, patients should
receive a more sophisticated mattress or overlay. A good
diet of eating well and drinking enough water is very
important. The healthcare professional will offer good
dietary advice according to what is patients missing from
the diet, their general health, and preferences.
Treatment group
In addition to standard wound care, all participants in
the treatment group will receive EA treatment. Hanyi
needles (0.17 × 7 mm; Tianjin Medical Appliance Factory,
Tianjin, China) and a Micro Plus transcutaneous electrical
nerve stimulator (BioMedical Life Systems, Inc, Vista, CA,
USA) will be used in the trial. Two needles will be punc-
tured into the skin of the local wound. One needle will be
inserted into the wound center with a 90° angle and
connected with the negative pole, while the other needle
will be punctured in the normal skin 0.5 cm away from
the ulcer margin with a 45° angle and connected with the
positive pole. Both needles will be applied without lifting,
thrusting, or rotating. The electric stimulator will be
turned on with 500 μA, 0.5 Hz, 30 minutes each time, for
five sessions per week for 8 weeks.
Outcome measures
Primary outcome
1) Wound surface area (WSA)
The pressure ulcer surface area will be measured by
the use of acetate tracing and subsequent planimetric
determination. Ulcer tracings will be accomplished by
outlining the pressure ulcer circumference onto a trans-
parent film applied directly over the wound. Each ulcer
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in order to improve the accuracy of the tracings. The
ulcer surface area will be determined from the wound
tracing using a planimeter (KP-21C) by a third assessor.
All three assessors will be blinded as to the identity of
the patient and to the treatment group assignment.
Secondary outcome
1) Visual analogue scale (VAS)
The pain intensity of pressure ulcers will be assessed
using the 10 cm VAS (0, absence of pain; 10, worst pain
imaginable) [19,20]. The VAS was selected as a second-
ary outcome measurement in order to evaluate the
clinical severity and impact on activities of daily life in
patients with pressure ulcers.
2) Proportion of ulcers healed within trial
period (PUHTP)
The complete healed ulcers were defined as 100%
epithelization or skin closure without drainage.
Statistical methods
Sample size
This study is a pilot study for the evaluation of the
efficacy of EA for patients with pressure ulcers and the
feasibility of a large clinical trial. Because of the short
duration, lasting 8 weeks, the desired sample size for this
pilot study is 36 participants, with 18 participants in
each group, assuming a dropout rate of 20%, which is
the minimum sample size necessary to evaluate the
effect of EA [21].
Analysis
Data will be analyzed by a statistician blinded to the
allocation of groups. Statistical analyses will be con-
ducted using the SPSS 17.0 statistical software packages
(IBM, Armonk, NY, USA), and the levels of significance
will be reported at P <0.05. The intention-to-treat (ITT)
population will be defined as the participants who are
randomized and received at least one treatment session.
The data analysis of baseline characteristics, as well as
the primary and secondary outcomes will be based on
the ITT principle. Analysis of covariance will be con-
ducted unless the adjustment for possible baseline
incomparability is needed.
Data handling
Investigators will enter the collected data required by
the protocol into the case report forms. Non-obvious
errors or omissions will be recorded on data query forms,
which will be returned to the researchers’ workshop forresolution. The data from all centers will be pooled and
summarized with respect to demographic baseline charac-
teristics, effectiveness, and safety observations.Patient safety
Any adverse experiences (known as unfavorable or
unintended signs, symptoms, or diseases occurring after
treatment) related to EA treatment will be monitored.
The research team will review all trial protocols, monitor
participant safety, and investigate any adverse events.
The trials will be terminated if there are concerns about
patient safety.Quality control
All staff will be required to undergo special training,
including patient selection and exclusion, completing
the case report form, and acupuncture method, before
participating in the trial. Monitors will check case report
forms and EA operation at the participating hospital
once a month. Drop-outs and withdrawals (and the
reasons) from the study will be fully documented through-
out the treatment and follow-up periods.Ethics
Written informed consent will be obtained from each
participant. This study is approved by the ethical review
boards of the Second Affiliated Hospital of Heilongjiang
University of Traditional Chinese Medicine.Discussion
Pressure ulcers remain a major public health problem.
The results of this study will determine if EA is an
effective intervention for patients with pressure ulcers.
The results will also identify whether this therapy
focuses on symptomatic relief.
Acupuncture, a kind of TCM, has been a form of
healthcare in China for thousands of years. It has been
reported to be of some benefit to patients with pressure
ulcers, and could also enhance some of their signs and
symptoms.
Currently, there are no randomized controlled trials
(RCTs) about EA treatment for patients with pressure
ulcers; therefore, we designed this study. This study aims
to conduct a pilot study for a full-scale trial of EA for
pressure ulcers, and to examine its potential effect in
terms of pressure ulcers of future episodes. In addition,
it also provides the feasibility of a larger clinical trial.
The data pooled will shed new light on acupuncture,
especially for EA intervention for pressure ulcers.Trial status
The trial is currently recruiting participants.
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